Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Octreotide × 90 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 2 Gastro-enteropancreatic neuroendocrine tumor 2 Adenoma, Islet Cell 2 Recurrence 1 Pancreatitis 1 Pancreatic Intraductal Neoplasms 1 Fistula 1 Duodenal Neoplasms 1 Carcinoid Tumor 1

Interventions

atezolizumab 3 Etoposide 2 Cisplatin 2 zimberelimab 1 tivozanib 1 durvalumab 1 cabozantinib 1 belinostat 1 Temozolomide 1 Standard of Care 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Capecitabine 1 CTLA-4 Antigen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡